Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM12078) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
GDF7
|
||||||
Official Full Name |
Growth Differentiation Factor 7
|
||||||
Synonym |
BMP12;Growth Differentiation Factor 7;GDF-7;Growth/Differentiation Factor 7
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr2(Start:20667144 - End:20679243)
|
||||||
Strand |
+
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
2C30: Melanoma of skin | Cutaneous Melanoma [Melanoma of skin] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A00: Parkinsonism | Parkinson's disease (PD) [Parkinsonism] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
LD2C: Overgrowth syndromes | Sotos syndrome(SS) [Overgrowth syndromes] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH4XG8: Chronic myeloid leukaemia | Chronic Phase-Chronic Myeloid Leukemia [Chronic myeloid leukaemia] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: Docosahexaenoic acid | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Docosahexaenoic acid could altere the DNA methylation of GDF7 CpG loci.(cg18946478)
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.